Commentary: Six questions answered about breakthrough infections
Vaccines don’t ward off every single infection but they do massively lower the risk. (Education Images | Universal Images Group via Getty Images)
If you’ve been fully vaccinated against COVID-19, maybe you figured you no longer need to worry about contracting the coronavirus. But along with the rising number of new COVID-19 cases globally and growing concern about highly transmissible strains like the Delta variant come reports of fully vaccinated people testing positive for COVID-19.
As scary as the term may sound, the bottom line is that the existing COVID-19 vaccines are still very good at preventing symptomatic infections, and breakthrough infections happen very rarely. But just how common and how dangerous are they? Here’s a guide to what you need to know.
What is ‘breakthrough infection?’
No vaccine is 100 percent effective. Dr. Jonas Salk’s polio vaccine was 80 percent to 90 percent effective in preventing paralytic disease. Even for the gold standard measles vaccine, the efficacy was 94 percent among a highly vaccinated population during large outbreaks.
A quick reminder: A vaccine efficacy of 95 percent does not mean that the shot protects 95 percent of people while the other 5 percent will contract the virus. Vaccine efficacy is a measure of relative risk – you need to compare a group of vaccinated people to a group of unvaccinated people under the same exposure conditions. So consider a three-month study period during which 100 out of 10,000 unvaccinated people got COVID-19. You’d expect five vaccinated people to get sick during that same time. That’s 5 percent of the 100 unvaccinated people who fell ill, not 5 percent of the whole group of 10,000.
When people get infected after vaccination, scientists call these cases “breakthrough” infections because the virus broke through the protective barrier the vaccine provides.
How common is COVID-19 infection in the fully vaccinated?
Breakthrough infections are a little more frequent than previously expected and are probably increasing because of growing dominance of the Delta variant. But infections in vaccinated people are still very rare and usually cause mild or no symptoms.
For instance, 46 U.S. states and territories voluntarily reported 10,262 breakthrough infections to the U.S. Centers for Disease Control and Prevention between Jan. 1 and April 30. By comparison, there were 11.8 million COVID-19 diagnoses in total during the same period.
Beginning May 1, the CDC stopped monitoring vaccine breakthrough cases unless they resulted in hospitalization or death. Through July 19, there were 5,914 patients with COVID-19 vaccine breakthrough infections who were hospitalized or died in the U.S., out of more than 159 million people fully vaccinated nationwide.
One study between Dec. 15, 2020, and March 31, 2021, that included 258,716 veterans who received two doses of the Pfizer or Moderna vaccine, counted 410 who got breakthrough infections – that’s 0.16 percent of the total. Similarly, a study in New York noted 86 cases of COVID-19 breakthrough infections between Feb. 1 and April 30 among 126,367 people who were fully vaccinated, mostly with mRNA vaccines. This accounts for 1.2 percent of total COVID-19 cases and 0.07 percent of the fully vaccinated population.
How serious is a COVID-19 breakthrough infection?
The CDC defines a vaccine breakthrough infection as one in which a nasal swab can detect the SARS-CoV-2 RNA or protein more than 14 days after a person has completed the full recommended doses of an FDA-authorized COVID-19 vaccine.
Note that a breakthrough infection doesn’t necessarily mean the person feels sick – and in fact, 27 percent of breakthrough cases reported to the CDC were asymptomatic. Only 10 percent of the breakthrough-infected people were known to be hospitalized (some for reasons other than COVID-19), and 2 percent died. For comparison, during the spring of 2020 when vaccines were not yet available, over 6 percent of confirmed infections were fatal.
In a study at U.S. military treatment facilities, none of the breakthrough infections led to hospitalization. In another study, after just one dose of Pfizer vaccine the vaccinated people who tested positive for COVID-19 had a quarter less virus in their bodies than those who were unvaccinated and tested positive.
What makes a breakthrough infection more likely?
Nationwide, on average more than 5 percent of COVID-19 tests are coming back positive; in Alabama, Mississippi, and Oklahoma, the positivity rate is above 30 percent. Lots of coronavirus circulating in a community pushes the chance of breakthrough infections higher.
The likelihood is greater in situations of close contact, such as in a cramped working space, party, restaurant, or stadium. Breakthrough infections are also more likely among health care workers who are in frequent contact with infected patients.
For reasons that are unclear, nationwide CDC data found that women account for 63 percent of breakthrough infections. Some smaller studies identified women as the majority of breakthrough cases as well.
Vaccines trigger a less robust immune response among older people, and the chances of a breakthrough infection get higher with increasing age. Among the breakthrough cases tracked by the CDC, 75 percent occurred in patients age 65 and older.
Being immunocompromised or having underlying conditions such as high blood pressure, diabetes, heart disease, chronic kidney and lung diseases, and cancer increase the chances of breakthrough infections and can lead to severe COVID-19. For example, fully vaccinated organ transplant recipients were 82 times more likely to get a breakthrough infection and had a 485-fold higher risk of hospitalization and death after a breakthrough infection compared with the vaccinated general population in one study.
How do variants like Delta change things?
Two doses of the mRNA vaccines were only 79 percent effective at preventing symptomatic disease with Delta, compared with 89 percent effective in the case of the earlier Alpha variant, according to Public Health England. A single dose was only 35 percent protective against Delta.
About 12.5 percent of the 229,218 Delta variant cases across England through July 19 were among fully vaccinated people.
Israel, with high vaccination rates, has reported that full vaccination with the Pfizer vaccine might be only 39-40.5 percent effective at preventing Delta variant infections of any severity, down from early estimates of 90 percent. Israel’s findings suggest that within six months, COVID-19 vaccines’ efficacy at preventing infection and symptomatic disease declines. The good news, though, is that the vaccine is still highly effective at protecting against hospitalization (88 percent) and severe illness (91.4 percent) caused by the now-dominant Delta variant.
So how well are vaccines holding up?
As of the end of July, 49.1 percent of the U.S. population, or just over 163 million people, are fully vaccinated. Nearly 90 percent of Americans over the age of 65 have received at least one dose of a vaccine.
Scientists’ models suggest that vaccination may have saved approximately 279,000 lives in the United States and prevented up to 1.25 million hospitalizations by the end of June 2021. Similarly, in England about 30,300 deaths, 46,300 hospitalizations, and 8.15 million infections may have been prevented by COVID-19 vaccines. In Israel, the high vaccination rate is thought to have caused a 77 percent drop in cases and a 68 percent drop in hospitalizations from that nation’s pandemic peak.
Across the United States, only 150 out of more than 18,000 deaths due to COVID-19 in May were of people who had been fully vaccinated. That means nearly all COVID-19 deaths in U.S. are among those who remain unvaccinated.
The United States is becoming “almost like two Americas,” as Anthony Fauci put it, divided between the vaccinated and the unvaccinated. Those who have not been fully vaccinated against COVID-19 remain at risk from the coronavirus that has so far killed more than 600,000 people in the United States.
Our stories may be republished online or in print under Creative Commons license CC BY-NC-ND 4.0. We ask that you edit only for style or to shorten, provide proper attribution and link to our web site. Please see our republishing guidelines for use of photos and graphics.